| http://www.w3.org/ns/prov#value | - ticoagulated with an agent such as Coumadin or heparin will be allowed to participate provided that no prior evidence of underlying abnormality in these parameters exists) Sponsor:National Cancer Institute (NCI)Dates:February 2010Last Updated:December 4, 2014Study HIC#:Clinicaltrials.gov ID: NCT01015833For more information about this trial, contact:Stacey M. Stein203-785-5702?? Yale School of Medi
|
